LifePROTEKT Reports great news for Alzheimers patients

April 14, Dr. Norman Relkin, director of the Memory Disorders Program at New York-Presbyterian/Weill Cornell, reported to the American Academy of Neurology the results of an 18 month long study. The research involved the administration of human blood antibodies or IGIV ( Immune Globulin Intravenous/ Human) to Alzheimers patients once or twice a month. The [...]


























Follow Us: